Rank | Gene Set | Z-score |
---|---|---|
1 | histamine secretion (GO:0001821) | 5.61540099 |
2 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.94139149 |
3 | axon ensheathment in central nervous system (GO:0032291) | 4.68304385 |
4 | central nervous system myelination (GO:0022010) | 4.68304385 |
5 | fatty acid elongation (GO:0030497) | 4.57837895 |
6 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.54605164 |
7 | histamine transport (GO:0051608) | 4.30876683 |
8 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.22732827 |
9 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.22050933 |
10 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.12094857 |
11 | response to muramyl dipeptide (GO:0032495) | 4.05281551 |
12 | positive regulation of interleukin-2 production (GO:0032743) | 4.01811085 |
13 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.94540610 |
14 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.93607734 |
15 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.86416787 |
16 | T-helper cell differentiation (GO:0042093) | 3.86416787 |
17 | acrosome reaction (GO:0007340) | 3.85950869 |
18 | L-phenylalanine catabolic process (GO:0006559) | 3.83141771 |
19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.83141771 |
20 | negative regulation of neurotransmitter transport (GO:0051589) | 3.71610192 |
21 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.68423108 |
22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.67563069 |
23 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.65487399 |
24 | response to peptidoglycan (GO:0032494) | 3.56501946 |
25 | establishment of protein localization to Golgi (GO:0072600) | 3.50083663 |
26 | presynaptic membrane assembly (GO:0097105) | 3.49157362 |
27 | regulation of sarcomere organization (GO:0060297) | 3.46376817 |
28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.45235020 |
29 | microglial cell activation (GO:0001774) | 3.42542307 |
30 | regulation of interferon-alpha production (GO:0032647) | 3.41492388 |
31 | nucleotide transmembrane transport (GO:1901679) | 3.41460483 |
32 | glycerophospholipid catabolic process (GO:0046475) | 3.39427278 |
33 | positive regulation of interferon-alpha production (GO:0032727) | 3.37455715 |
34 | myelination (GO:0042552) | 3.34833119 |
35 | presynaptic membrane organization (GO:0097090) | 3.32253526 |
36 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.31012549 |
37 | axon ensheathment (GO:0008366) | 3.30950711 |
38 | ensheathment of neurons (GO:0007272) | 3.30950711 |
39 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.30000249 |
40 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.30000249 |
41 | T cell differentiation involved in immune response (GO:0002292) | 3.30000249 |
42 | artery smooth muscle contraction (GO:0014824) | 3.27215334 |
43 | positive regulation of B cell differentiation (GO:0045579) | 3.26064053 |
44 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.25973764 |
45 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.23460226 |
46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.23460226 |
47 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.21839994 |
48 | ER overload response (GO:0006983) | 3.21451919 |
49 | regulation of interleukin-2 production (GO:0032663) | 3.19844246 |
50 | regulation of heat generation (GO:0031650) | 3.19542118 |
51 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.18755259 |
52 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.16661346 |
53 | tryptophan metabolic process (GO:0006568) | 3.16427406 |
54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16381362 |
55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16381362 |
56 | modulation by symbiont of host immune response (GO:0052553) | 3.16381362 |
57 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16381362 |
58 | modulation by symbiont of host defense response (GO:0052031) | 3.16381362 |
59 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16381362 |
60 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.14556309 |
61 | negative regulation of B cell mediated immunity (GO:0002713) | 3.14556309 |
62 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.14507222 |
63 | positive regulation of interleukin-10 production (GO:0032733) | 3.14446501 |
64 | response to redox state (GO:0051775) | 3.13718569 |
65 | regulation of T-helper cell differentiation (GO:0045622) | 3.13058154 |
66 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.12531018 |
67 | cellular extravasation (GO:0045123) | 3.12512032 |
68 | import into cell (GO:0098657) | 3.04989946 |
69 | regulation of hypersensitivity (GO:0002883) | 3.04531299 |
70 | regulation of germinal center formation (GO:0002634) | 3.03348952 |
71 | azole transport (GO:0045117) | 3.02479695 |
72 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.02045656 |
73 | negative regulation of interleukin-12 production (GO:0032695) | 3.01520011 |
74 | dopamine biosynthetic process (GO:0042416) | 3.01060070 |
75 | regulation of interleukin-4 production (GO:0032673) | 2.96833755 |
76 | L-phenylalanine metabolic process (GO:0006558) | 2.94568935 |
77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.94568935 |
78 | response to pheromone (GO:0019236) | 2.94435407 |
79 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.92046179 |
80 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91044287 |
81 | myeloid leukocyte mediated immunity (GO:0002444) | 2.90002483 |
82 | creatine metabolic process (GO:0006600) | 2.88675088 |
83 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.87567485 |
84 | regulation of fever generation (GO:0031620) | 2.86079227 |
85 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84122307 |
86 | regulation of interleukin-10 production (GO:0032653) | 2.83890928 |
87 | cholesterol biosynthetic process (GO:0006695) | 2.82976227 |
88 | regulation of metalloenzyme activity (GO:0048552) | 2.80820645 |
89 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.80488251 |
90 | positive regulation of interleukin-12 production (GO:0032735) | 2.79365130 |
91 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.79311469 |
92 | regulation of alpha-beta T cell activation (GO:0046634) | 2.79116323 |
93 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.78817046 |
94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77757006 |
95 | aromatic amino acid family catabolic process (GO:0009074) | 2.75574749 |
96 | positive regulation of heat generation (GO:0031652) | 2.75497877 |
97 | tonic smooth muscle contraction (GO:0014820) | 2.74586819 |
98 | neutrophil chemotaxis (GO:0030593) | 2.74392027 |
99 | germinal center formation (GO:0002467) | 2.73878078 |
100 | macrophage activation involved in immune response (GO:0002281) | 2.73749808 |
101 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.73362724 |
102 | regulation of chemokine biosynthetic process (GO:0045073) | 2.72813136 |
103 | indolalkylamine metabolic process (GO:0006586) | 2.71896364 |
104 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.71411281 |
105 | neutrophil migration (GO:1990266) | 2.66240130 |
106 | superoxide anion generation (GO:0042554) | 2.65588752 |
107 | histone H3-K36 demethylation (GO:0070544) | 2.65535057 |
108 | protein localization to Golgi apparatus (GO:0034067) | 2.65295655 |
109 | regulation of interleukin-12 production (GO:0032655) | 2.64839233 |
110 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.62987432 |
111 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.62842097 |
112 | cellular glucuronidation (GO:0052695) | 2.60504613 |
113 | positive regulation of acute inflammatory response (GO:0002675) | 2.59674182 |
114 | glucuronate metabolic process (GO:0019585) | 2.59343789 |
115 | uronic acid metabolic process (GO:0006063) | 2.59343789 |
116 | apical protein localization (GO:0045176) | 2.58979218 |
117 | cell wall macromolecule catabolic process (GO:0016998) | 2.58770876 |
118 | regulation of lipoprotein metabolic process (GO:0050746) | 2.58384892 |
119 | T cell migration (GO:0072678) | 2.55831485 |
120 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.53441624 |
121 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.53331419 |
122 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.53061776 |
123 | response to methylmercury (GO:0051597) | 2.52946145 |
124 | limb bud formation (GO:0060174) | 2.52462473 |
125 | regulation of B cell mediated immunity (GO:0002712) | 2.52137680 |
126 | oligodendrocyte differentiation (GO:0048709) | 2.51554725 |
127 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.51013296 |
128 | phagocytosis, engulfment (GO:0006911) | 2.50927174 |
129 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50680092 |
130 | photoreceptor cell differentiation (GO:0046530) | 2.50142461 |
131 | eye photoreceptor cell differentiation (GO:0001754) | 2.50142461 |
132 | response to dietary excess (GO:0002021) | 2.49950517 |
133 | macrophage activation (GO:0042116) | 2.49330391 |
134 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.48833415 |
135 | B cell mediated immunity (GO:0019724) | 2.48704845 |
136 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.48140421 |
137 | neutrophil mediated immunity (GO:0002446) | 2.47709696 |
138 | regulation of beta-amyloid formation (GO:1902003) | 2.47012382 |
139 | asymmetric protein localization (GO:0008105) | 2.46776670 |
140 | succinate metabolic process (GO:0006105) | 2.45759994 |
141 | negative regulation of JUN kinase activity (GO:0043508) | 2.45270044 |
142 | very long-chain fatty acid metabolic process (GO:0000038) | 2.43507730 |
143 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.43062504 |
144 | neuron cell-cell adhesion (GO:0007158) | 2.42723211 |
145 | sterol biosynthetic process (GO:0016126) | 2.42545939 |
146 | iron ion import (GO:0097286) | 2.41633765 |
147 | coenzyme catabolic process (GO:0009109) | 2.40521027 |
148 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.35389129 |
149 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.34833815 |
150 | positive regulation of action potential (GO:0045760) | 2.33415069 |
151 | bile acid biosynthetic process (GO:0006699) | 2.33282922 |
152 | myelin maintenance (GO:0043217) | 2.32669291 |
153 | thioester biosynthetic process (GO:0035384) | 2.32330252 |
154 | acyl-CoA biosynthetic process (GO:0071616) | 2.32330252 |
155 | prostate gland growth (GO:0060736) | 2.31904293 |
156 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.31407501 |
157 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.29358511 |
158 | nucleotide transport (GO:0006862) | 2.28158289 |
159 | neurotransmitter catabolic process (GO:0042135) | 2.26338818 |
160 | chondrocyte development (GO:0002063) | 2.26299539 |
161 | complement activation, alternative pathway (GO:0006957) | 2.25836884 |
162 | Golgi to plasma membrane protein transport (GO:0043001) | 2.24634117 |
163 | response to lipoprotein particle (GO:0055094) | 2.19533991 |
164 | substantia nigra development (GO:0021762) | 2.18953376 |
165 | protein targeting to Golgi (GO:0000042) | 2.18597990 |
166 | regulation of energy homeostasis (GO:2000505) | 2.18527257 |
167 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.18339738 |
168 | negative regulation of protein localization to cell surface (GO:2000009) | 2.16219740 |
169 | transmission of nerve impulse (GO:0019226) | 2.15708088 |
170 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.15069995 |
171 | branched-chain amino acid catabolic process (GO:0009083) | 2.14272952 |
172 | tyrosine metabolic process (GO:0006570) | 2.14269046 |
173 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.14127061 |
174 | detection of calcium ion (GO:0005513) | 2.13051540 |
175 | thioester metabolic process (GO:0035383) | 2.11248642 |
176 | acyl-CoA metabolic process (GO:0006637) | 2.11248642 |
177 | acetyl-CoA metabolic process (GO:0006084) | 2.10289208 |
178 | negative regulation of exocytosis (GO:0045920) | 2.05361742 |
179 | regulation of cell communication by electrical coupling (GO:0010649) | 2.04992984 |
180 | indole-containing compound catabolic process (GO:0042436) | 2.04930539 |
181 | indolalkylamine catabolic process (GO:0046218) | 2.04930539 |
182 | tryptophan catabolic process (GO:0006569) | 2.04930539 |
183 | positive regulation of amino acid transport (GO:0051957) | 2.04002878 |
184 | protein K11-linked deubiquitination (GO:0035871) | 2.03996514 |
185 | regulation of collateral sprouting (GO:0048670) | 2.03899918 |
186 | virion attachment to host cell (GO:0019062) | 2.03541829 |
187 | adhesion of symbiont to host cell (GO:0044650) | 2.03541829 |
188 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.03391192 |
189 | regulation of sequestering of triglyceride (GO:0010889) | 2.02928313 |
190 | nerve growth factor signaling pathway (GO:0038180) | 2.02473560 |
191 | positive regulation of glycolytic process (GO:0045821) | 2.00693629 |
192 | L-amino acid import (GO:0043092) | 2.00139292 |
193 | phosphatidylethanolamine metabolic process (GO:0046337) | 1.99885118 |
194 | cofactor catabolic process (GO:0051187) | 1.99095031 |
195 | short-term memory (GO:0007614) | 1.98934618 |
196 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.97825821 |
197 | amine catabolic process (GO:0009310) | 1.97321889 |
198 | cellular biogenic amine catabolic process (GO:0042402) | 1.97321889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02441820 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51887175 |
3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.27957966 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.98264104 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90545219 |
6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.67164457 |
7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.67164457 |
8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.67164457 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58336521 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.51133601 |
11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.47140969 |
12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38495369 |
13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36276398 |
14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.27658688 |
15 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.26321250 |
16 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.20875210 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.18546246 |
18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.12956674 |
19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08990656 |
20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08110305 |
21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.06515349 |
22 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.01762325 |
23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.97290053 |
24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.97250949 |
25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88244863 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86633584 |
27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85651561 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.84519500 |
29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78581807 |
30 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.78290869 |
31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.75409098 |
32 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.75237396 |
33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.74718524 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72273692 |
35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.71847379 |
36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71442554 |
37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71217800 |
38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.70276032 |
39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66741763 |
40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65973764 |
41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.65797599 |
42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.65797599 |
43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64328426 |
44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.64280018 |
45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63733896 |
46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61086031 |
47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60042500 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58750126 |
49 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.56730905 |
50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.56172982 |
51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56110720 |
52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.55647964 |
53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55647964 |
54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55413653 |
55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54592290 |
56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54550416 |
57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54207538 |
58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53316108 |
59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.51661668 |
60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49936902 |
61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49464669 |
62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47177525 |
63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46369631 |
64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45886308 |
65 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45696338 |
66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45499295 |
67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.45192564 |
68 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45128457 |
69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43535663 |
70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42907908 |
71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41894563 |
72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41321792 |
73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40759515 |
74 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40652446 |
75 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40362297 |
76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37063603 |
77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36972241 |
78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35883623 |
79 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.35629322 |
80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35059729 |
81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.33615633 |
82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33027886 |
83 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32536760 |
84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32175485 |
85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.30393128 |
86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29472769 |
87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29456497 |
88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29384712 |
89 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.28520663 |
90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28443862 |
91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27517785 |
92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27475582 |
93 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.26738443 |
94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.26640326 |
95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25526759 |
96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25055884 |
97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.24982772 |
98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24570130 |
99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24344720 |
100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23523727 |
101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23025430 |
102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23025430 |
103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22256779 |
104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22066379 |
105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20703143 |
106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19818274 |
107 | AR_25329375_ChIP-Seq_VCAP_Human | 1.19230262 |
108 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19094704 |
109 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.18693385 |
110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.18013461 |
111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16832380 |
112 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16592907 |
113 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16125267 |
114 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15807540 |
115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15601906 |
116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14891174 |
117 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14295245 |
118 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14002812 |
119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13943062 |
120 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13843549 |
121 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13684988 |
122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13046466 |
123 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12740668 |
124 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.12400594 |
125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11831721 |
126 | MYB_26560356_Chip-Seq_TH1_Human | 1.11382503 |
127 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.11156449 |
128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11050673 |
129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10522575 |
130 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10183398 |
131 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08196394 |
132 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07733176 |
133 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07505893 |
134 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07505893 |
135 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07330764 |
136 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.06547254 |
137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06201643 |
138 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06061424 |
139 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04820548 |
140 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04292376 |
141 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04181970 |
142 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04081449 |
143 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02437730 |
144 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02107175 |
145 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01699209 |
146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01068552 |
147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01068552 |
148 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00931748 |
149 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00440180 |
150 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.99754418 |
151 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99180465 |
152 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97487334 |
153 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96315155 |
154 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96291458 |
155 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95983977 |
156 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95783080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.07097678 |
2 | MP0003724_increased_susceptibility_to | 3.93501130 |
3 | MP0002139_abnormal_hepatobiliary_system | 3.18622743 |
4 | MP0009780_abnormal_chondrocyte_physiolo | 3.02610108 |
5 | MP0003690_abnormal_glial_cell | 3.00494986 |
6 | MP0009278_abnormal_bone_marrow | 2.90816649 |
7 | MP0000920_abnormal_myelination | 2.82390399 |
8 | MP0003195_calcinosis | 2.82017855 |
9 | MP0005085_abnormal_gallbladder_physiolo | 2.68652234 |
10 | MP0001835_abnormal_antigen_presentation | 2.65145277 |
11 | MP0003880_abnormal_central_pattern | 2.56587626 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 2.54896591 |
13 | MP0006082_CNS_inflammation | 2.52386140 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.41483043 |
15 | MP0000569_abnormal_digit_pigmentation | 2.39347425 |
16 | MP0003436_decreased_susceptibility_to | 2.39336982 |
17 | MP0002166_altered_tumor_susceptibility | 2.29437994 |
18 | MP0002006_tumorigenesis | 2.28476745 |
19 | MP0005397_hematopoietic_system_phenotyp | 2.20830099 |
20 | MP0001545_abnormal_hematopoietic_system | 2.20830099 |
21 | MP0000372_irregular_coat_pigmentation | 2.17897879 |
22 | MP0005646_abnormal_pituitary_gland | 2.17566882 |
23 | MP0008877_abnormal_DNA_methylation | 2.15725032 |
24 | MP0002876_abnormal_thyroid_physiology | 2.15659970 |
25 | MP0001800_abnormal_humoral_immune | 2.15493144 |
26 | MP0002254_reproductive_system_inflammat | 2.11068608 |
27 | MP0005000_abnormal_immune_tolerance | 2.06377516 |
28 | MP0002419_abnormal_innate_immunity | 2.04520909 |
29 | MP0000013_abnormal_adipose_tissue | 2.00992531 |
30 | MP0005365_abnormal_bile_salt | 1.99847515 |
31 | MP0005671_abnormal_response_to | 1.98446709 |
32 | MP0003172_abnormal_lysosome_physiology | 1.92948226 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.89513269 |
34 | MP0004270_analgesia | 1.88854470 |
35 | MP0005387_immune_system_phenotype | 1.88436625 |
36 | MP0001790_abnormal_immune_system | 1.88436625 |
37 | MP0002723_abnormal_immune_serum | 1.86842643 |
38 | MP0009785_altered_susceptibility_to | 1.86053633 |
39 | MP0005167_abnormal_blood-brain_barrier | 1.81195379 |
40 | MP0005360_urolithiasis | 1.81030303 |
41 | MP0002452_abnormal_antigen_presenting | 1.80663610 |
42 | MP0004883_abnormal_blood_vessel | 1.77253348 |
43 | MP0004134_abnormal_chest_morphology | 1.75996135 |
44 | MP0009697_abnormal_copulation | 1.75881122 |
45 | MP0005379_endocrine/exocrine_gland_phen | 1.75459862 |
46 | MP0009840_abnormal_foam_cell | 1.74821092 |
47 | MP0009764_decreased_sensitivity_to | 1.68076856 |
48 | MP0005025_abnormal_response_to | 1.67214191 |
49 | MP0005645_abnormal_hypothalamus_physiol | 1.66422301 |
50 | MP0002272_abnormal_nervous_system | 1.66080327 |
51 | MP0005464_abnormal_platelet_physiology | 1.65570139 |
52 | MP0006054_spinal_hemorrhage | 1.64508838 |
53 | MP0001905_abnormal_dopamine_level | 1.59667337 |
54 | MP0002064_seizures | 1.56979699 |
55 | MP0004043_abnormal_pH_regulation | 1.56513325 |
56 | MP0003950_abnormal_plasma_membrane | 1.54671537 |
57 | MP0002420_abnormal_adaptive_immunity | 1.54488916 |
58 | MP0004130_abnormal_muscle_cell | 1.54150803 |
59 | MP0001486_abnormal_startle_reflex | 1.53996061 |
60 | MP0001529_abnormal_vocalization | 1.53089658 |
61 | MP0001819_abnormal_immune_cell | 1.51278254 |
62 | MP0002132_abnormal_respiratory_system | 1.47854446 |
63 | MP0001986_abnormal_taste_sensitivity | 1.47638847 |
64 | MP0001661_extended_life_span | 1.47010927 |
65 | MP0002405_respiratory_system_inflammati | 1.45196279 |
66 | MP0001533_abnormal_skeleton_physiology | 1.43005686 |
67 | MP0005164_abnormal_response_to | 1.39156097 |
68 | MP0005310_abnormal_salivary_gland | 1.38759634 |
69 | MP0002009_preneoplasia | 1.37585167 |
70 | MP0009745_abnormal_behavioral_response | 1.37426941 |
71 | MP0005166_decreased_susceptibility_to | 1.36548897 |
72 | MP0004036_abnormal_muscle_relaxation | 1.36107980 |
73 | MP0001501_abnormal_sleep_pattern | 1.35669673 |
74 | MP0001299_abnormal_eye_distance/ | 1.35567792 |
75 | MP0000003_abnormal_adipose_tissue | 1.35476297 |
76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35204394 |
77 | MP0000685_abnormal_immune_system | 1.34489186 |
78 | MP0008260_abnormal_autophagy | 1.32660466 |
79 | MP0003252_abnormal_bile_duct | 1.32294140 |
80 | MP0010368_abnormal_lymphatic_system | 1.30538850 |
81 | MP0001177_atelectasis | 1.28968093 |
82 | MP0002822_catalepsy | 1.26756707 |
83 | MP0003329_amyloid_beta_deposits | 1.24370245 |
84 | MP0002118_abnormal_lipid_homeostasis | 1.22864575 |
85 | MP0003656_abnormal_erythrocyte_physiolo | 1.22067374 |
86 | MP0005332_abnormal_amino_acid | 1.21331826 |
87 | MP0005535_abnormal_body_temperature | 1.20860034 |
88 | MP0003183_abnormal_peptide_metabolism | 1.20218537 |
89 | MP0003300_gastrointestinal_ulcer | 1.19506079 |
90 | MP0003122_maternal_imprinting | 1.19305418 |
91 | MP0008057_abnormal_DNA_replication | 1.18705797 |
92 | MP0009046_muscle_twitch | 1.17606998 |
93 | MP0005386_behavior/neurological_phenoty | 1.15243661 |
94 | MP0004924_abnormal_behavior | 1.15243661 |
95 | MP0002108_abnormal_muscle_morphology | 1.14225901 |
96 | MP0005171_absent_coat_pigmentation | 1.14149413 |
97 | MP0001440_abnormal_grooming_behavior | 1.14072132 |
98 | MP0003191_abnormal_cellular_cholesterol | 1.13396018 |
99 | MP0000716_abnormal_immune_system | 1.12652316 |
100 | MP0006276_abnormal_autonomic_nervous | 1.12319794 |
101 | MP0003635_abnormal_synaptic_transmissio | 1.12137044 |
102 | MP0002572_abnormal_emotion/affect_behav | 1.12133529 |
103 | MP0010155_abnormal_intestine_physiology | 1.11017297 |
104 | MP0002734_abnormal_mechanical_nocicepti | 1.10821848 |
105 | MP0002398_abnormal_bone_marrow | 1.10210839 |
106 | MP0008004_abnormal_stomach_pH | 1.08981265 |
107 | MP0003763_abnormal_thymus_physiology | 1.05637789 |
108 | MP0003634_abnormal_glial_cell | 1.05068198 |
109 | MP0002933_joint_inflammation | 1.03932362 |
110 | MP0004742_abnormal_vestibular_system | 1.03727259 |
111 | MP0001845_abnormal_inflammatory_respons | 1.02560674 |
112 | MP0000689_abnormal_spleen_morphology | 1.01921979 |
113 | MP0002063_abnormal_learning/memory/cond | 1.01886252 |
114 | MP0010329_abnormal_lipoprotein_level | 1.01351826 |
115 | MP0004145_abnormal_muscle_electrophysio | 0.99604765 |
116 | MP0002229_neurodegeneration | 0.98118052 |
117 | MP0002138_abnormal_hepatobiliary_system | 0.97917196 |
118 | MP0004147_increased_porphyrin_level | 0.97458639 |
119 | MP0001853_heart_inflammation | 0.97143820 |
120 | MP0000230_abnormal_systemic_arterial | 0.96749918 |
121 | MP0008469_abnormal_protein_level | 0.96559376 |
122 | MP0001963_abnormal_hearing_physiology | 0.91852024 |
123 | MP0001984_abnormal_olfaction | 0.91460062 |
124 | MP0004142_abnormal_muscle_tone | 0.89455409 |
125 | MP0005670_abnormal_white_adipose | 0.89195366 |
126 | MP0003632_abnormal_nervous_system | 0.88787516 |
127 | MP0000751_myopathy | 0.88661196 |
128 | MP0002295_abnormal_pulmonary_circulatio | 0.88348974 |
129 | MP0003633_abnormal_nervous_system | 0.88306661 |
130 | MP0000747_muscle_weakness | 0.87878908 |
131 | MP0005503_abnormal_tendon_morphology | 0.87351147 |
132 | MP0002909_abnormal_adrenal_gland | 0.87007545 |
133 | MP0003959_abnormal_lean_body | 0.86286678 |
134 | MP0001485_abnormal_pinna_reflex | 0.85897606 |
135 | MP0005174_abnormal_tail_pigmentation | 0.85701618 |
136 | MP0009250_abnormal_appendicular_skeleto | 0.85517767 |
137 | MP0000778_abnormal_nervous_system | 0.85157804 |
138 | MP0004885_abnormal_endolymph | 0.84253675 |
139 | MP0000604_amyloidosis | 0.83917632 |
140 | MP0005375_adipose_tissue_phenotype | 0.83179638 |
141 | MP0004947_skin_inflammation | 0.82887980 |
142 | MP0002722_abnormal_immune_system | 0.82882379 |
143 | MP0005409_darkened_coat_color | 0.81855629 |
144 | MP0002896_abnormal_bone_mineralization | 0.81805872 |
145 | MP0005058_abnormal_lysosome_morphology | 0.81712548 |
146 | MP0008438_abnormal_cutaneous_collagen | 0.81674704 |
147 | MP0003787_abnormal_imprinting | 0.81613837 |
148 | MP0004272_abnormal_basement_membrane | 0.81364956 |
149 | MP0004484_altered_response_of | 0.81167429 |
150 | MP0002067_abnormal_sensory_capabilities | 0.81013317 |
151 | MP0002429_abnormal_blood_cell | 0.80843959 |
152 | MP0002971_abnormal_brown_adipose | 0.80573792 |
153 | MP0002277_abnormal_respiratory_mucosa | 0.79393999 |
154 | MP0003631_nervous_system_phenotype | 0.78951534 |
155 | MP0002078_abnormal_glucose_homeostasis | 0.78662940 |
156 | MP0005408_hypopigmentation | 0.78646269 |
157 | MP0005334_abnormal_fat_pad | 0.78551386 |
158 | MP0001666_abnormal_nutrient_absorption | 0.78095184 |
159 | MP0000383_abnormal_hair_follicle | 0.77739798 |
160 | MP0005410_abnormal_fertilization | 0.77383644 |
161 | MP0010386_abnormal_urinary_bladder | 0.77222604 |
162 | MP0002998_abnormal_bone_remodeling | 0.77216717 |
163 | MP0000427_abnormal_hair_cycle | 0.76870474 |
164 | MP0002066_abnormal_motor_capabilities/c | 0.76448051 |
165 | MP0000371_diluted_coat_color | 0.76310938 |
166 | MP0003121_genomic_imprinting | 0.75637087 |
167 | MP0000249_abnormal_blood_vessel | 0.73798664 |
168 | MP0000343_altered_response_to | 0.73119224 |
169 | MP0009333_abnormal_splenocyte_physiolog | 0.67787746 |
170 | MP0009763_increased_sensitivity_to | 0.61896522 |
171 | MP0000516_abnormal_urinary_system | 0.60398072 |
172 | MP0005367_renal/urinary_system_phenotyp | 0.60398072 |
173 | MP0003646_muscle_fatigue | 0.59269697 |
174 | MP0001915_intracranial_hemorrhage | 0.57590346 |
175 | MP0000703_abnormal_thymus_morphology | 0.53586093 |
176 | MP0000465_gastrointestinal_hemorrhage | 0.53483664 |
177 | MP0000639_abnormal_adrenal_gland | 0.51884979 |
178 | MP0005390_skeleton_phenotype | 0.51141876 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 4.84812138 |
2 | Spontaneous hematomas (HP:0007420) | 4.79859631 |
3 | Panhypogammaglobulinemia (HP:0003139) | 4.16198884 |
4 | Hypoplastic ischia (HP:0003175) | 4.15406567 |
5 | Epiphyseal dysplasia (HP:0002656) | 3.97904898 |
6 | Abnormality of the ischium (HP:0003174) | 3.86395558 |
7 | Recurrent bacterial skin infections (HP:0005406) | 3.75316188 |
8 | Spinal muscular atrophy (HP:0007269) | 3.72193172 |
9 | Stenosis of the external auditory canal (HP:0000402) | 3.64870716 |
10 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.56975036 |
11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.56975036 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.42839719 |
13 | Optic neuritis (HP:0100653) | 3.42839719 |
14 | Stomach cancer (HP:0012126) | 3.35878979 |
15 | Abnormal tarsal ossification (HP:0008369) | 3.34320888 |
16 | Pheochromocytoma (HP:0002666) | 3.34231245 |
17 | Arterial tortuosity (HP:0005116) | 3.28113680 |
18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.23074513 |
19 | Neurofibrillary tangles (HP:0002185) | 3.22851702 |
20 | Irregular epiphyses (HP:0010582) | 3.19105521 |
21 | Neuroendocrine neoplasm (HP:0100634) | 3.15186205 |
22 | Intrahepatic cholestasis (HP:0001406) | 3.11421552 |
23 | Vitreoretinal degeneration (HP:0000655) | 3.10244239 |
24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.07004053 |
25 | Complement deficiency (HP:0004431) | 3.06200540 |
26 | Recurrent abscess formation (HP:0002722) | 3.03693847 |
27 | Barrel-shaped chest (HP:0001552) | 3.02228388 |
28 | Vascular tortuosity (HP:0004948) | 3.01124842 |
29 | Myositis (HP:0100614) | 3.00818729 |
30 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.00123667 |
31 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.00033616 |
32 | Chronic otitis media (HP:0000389) | 2.96120495 |
33 | Hypoglycemic seizures (HP:0002173) | 2.95218525 |
34 | Protuberant abdomen (HP:0001538) | 2.94818779 |
35 | Abnormality of the prostate (HP:0008775) | 2.94504178 |
36 | Abnormal foot bone ossification (HP:0010675) | 2.94058866 |
37 | Arthropathy (HP:0003040) | 2.92920901 |
38 | Metaphyseal dysplasia (HP:0100255) | 2.89340106 |
39 | Chronic diarrhea (HP:0002028) | 2.80016719 |
40 | Bladder carcinoma (HP:0002862) | 2.72187112 |
41 | Bladder neoplasm (HP:0009725) | 2.72187112 |
42 | Encephalitis (HP:0002383) | 2.71965372 |
43 | Abnormality of T cell number (HP:0011839) | 2.69619045 |
44 | Orchitis (HP:0100796) | 2.68966228 |
45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.68096727 |
46 | Small epiphyses (HP:0010585) | 2.65038877 |
47 | Hyperventilation (HP:0002883) | 2.64690195 |
48 | Atonic seizures (HP:0010819) | 2.62874101 |
49 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.62528511 |
50 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.58224340 |
51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.58064359 |
52 | T lymphocytopenia (HP:0005403) | 2.56497647 |
53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56217141 |
54 | Insidious onset (HP:0003587) | 2.53752181 |
55 | Termporal pattern (HP:0011008) | 2.53752181 |
56 | Osteomyelitis (HP:0002754) | 2.53748673 |
57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.45535182 |
58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.45412797 |
59 | Leukocytosis (HP:0001974) | 2.44270699 |
60 | Hematochezia (HP:0002573) | 2.43658327 |
61 | Disproportionate short-trunk short stature (HP:0003521) | 2.43403280 |
62 | Autoamputation (HP:0001218) | 2.42507453 |
63 | Abnormality of the corticospinal tract (HP:0002492) | 2.42457404 |
64 | Recurrent viral infections (HP:0004429) | 2.42132708 |
65 | Enlarged kidneys (HP:0000105) | 2.40604295 |
66 | Hypoglycemic coma (HP:0001325) | 2.40429418 |
67 | Cerebral hemorrhage (HP:0001342) | 2.40348161 |
68 | Recurrent skin infections (HP:0001581) | 2.40102726 |
69 | Mediastinal lymphadenopathy (HP:0100721) | 2.39680937 |
70 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.35799149 |
71 | Irregular vertebral endplates (HP:0003301) | 2.35062229 |
72 | Symptomatic seizures (HP:0011145) | 2.34573965 |
73 | Bell-shaped thorax (HP:0001591) | 2.34342307 |
74 | Decreased central vision (HP:0007663) | 2.33801841 |
75 | Abnormal hair whorl (HP:0010721) | 2.33540976 |
76 | Alveolar cell carcinoma (HP:0006519) | 2.31143379 |
77 | Abnormality of the vertebral endplates (HP:0005106) | 2.28664596 |
78 | Cerebral inclusion bodies (HP:0100314) | 2.28384823 |
79 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.27910113 |
80 | Mutism (HP:0002300) | 2.27316098 |
81 | Keratoconjunctivitis (HP:0001096) | 2.27071985 |
82 | Vasculitis (HP:0002633) | 2.26559459 |
83 | Disinhibition (HP:0000734) | 2.24604173 |
84 | Keratoconjunctivitis sicca (HP:0001097) | 2.24152644 |
85 | Abnormality of incisor morphology (HP:0011063) | 2.22327239 |
86 | Abnormality of B cell number (HP:0010975) | 2.22274487 |
87 | Exercise-induced myalgia (HP:0003738) | 2.22261458 |
88 | Xanthomatosis (HP:0000991) | 2.21841139 |
89 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.20808840 |
90 | Abnormality of the vitreous humor (HP:0004327) | 2.20344728 |
91 | Pulmonary embolism (HP:0002204) | 2.19660889 |
92 | Cupped ribs (HP:0000887) | 2.19491486 |
93 | Attenuation of retinal blood vessels (HP:0007843) | 2.16603034 |
94 | Episodic fever (HP:0001954) | 2.16479797 |
95 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.14905937 |
96 | Absent/shortened dynein arms (HP:0200106) | 2.14905937 |
97 | Prolonged partial thromboplastin time (HP:0003645) | 2.14823895 |
98 | Sensory axonal neuropathy (HP:0003390) | 2.14327461 |
99 | Abnormality of eosinophils (HP:0001879) | 2.12426492 |
100 | Recurrent sinusitis (HP:0011108) | 2.12382982 |
101 | Hyperlipoproteinemia (HP:0010980) | 2.11414013 |
102 | Gingival bleeding (HP:0000225) | 2.10808109 |
103 | Agnosia (HP:0010524) | 2.10469353 |
104 | Abnormality of complement system (HP:0005339) | 2.09368544 |
105 | Autoimmune thrombocytopenia (HP:0001973) | 2.08530417 |
106 | Broad ribs (HP:0000885) | 2.07364312 |
107 | Meningitis (HP:0001287) | 2.06689013 |
108 | Delayed epiphyseal ossification (HP:0002663) | 2.05522975 |
109 | Pendular nystagmus (HP:0012043) | 2.04881988 |
110 | Eczematoid dermatitis (HP:0000976) | 2.03826297 |
111 | Hypophosphatemic rickets (HP:0004912) | 2.03612447 |
112 | Abnormality of T cells (HP:0002843) | 2.03321622 |
113 | Hyperglycemia (HP:0003074) | 2.02871931 |
114 | Gangrene (HP:0100758) | 2.02038565 |
115 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.99811301 |
116 | Abnormality of the lumbar spine (HP:0100712) | 1.99491348 |
117 | Eosinophilia (HP:0001880) | 1.99247318 |
118 | Enlarged epiphyses (HP:0010580) | 1.99165291 |
119 | Pulmonary infiltrates (HP:0002113) | 1.98636434 |
120 | Thrombophlebitis (HP:0004418) | 1.98329285 |
121 | Abnormality of male internal genitalia (HP:0000022) | 1.97887857 |
122 | Generalized myoclonic seizures (HP:0002123) | 1.97771896 |
123 | Viral hepatitis (HP:0006562) | 1.97629773 |
124 | Recurrent fungal infections (HP:0002841) | 1.96173870 |
125 | Azoospermia (HP:0000027) | 1.96148906 |
126 | Glomerulonephritis (HP:0000099) | 1.96137429 |
127 | Prostate neoplasm (HP:0100787) | 1.94152598 |
128 | Basal cell carcinoma (HP:0002671) | 1.93027188 |
129 | Deep venous thrombosis (HP:0002625) | 1.93017422 |
130 | Abnormal vertebral ossification (HP:0100569) | 1.92548857 |
131 | Autoimmune hemolytic anemia (HP:0001890) | 1.92522970 |
132 | Blue irides (HP:0000635) | 1.90373917 |
133 | Abnormality of T cell physiology (HP:0011840) | 1.89883584 |
134 | Amyloidosis (HP:0011034) | 1.89689915 |
135 | Abnormality of the femoral head (HP:0003368) | 1.89244027 |
136 | Agammaglobulinemia (HP:0004432) | 1.88169135 |
137 | Spontaneous abortion (HP:0005268) | 1.87747643 |
138 | Scanning speech (HP:0002168) | 1.87359927 |
139 | Abnormality of the intrinsic pathway (HP:0010989) | 1.86226971 |
140 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85741834 |
141 | Mild short stature (HP:0003502) | 1.85116473 |
142 | Cerebral edema (HP:0002181) | 1.84588787 |
143 | Acute hepatic failure (HP:0006554) | 1.83504822 |
144 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82840264 |
145 | Facial diplegia (HP:0001349) | 1.82282944 |
146 | Ketosis (HP:0001946) | 1.81128866 |
147 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80665299 |
148 | Increased IgM level (HP:0003496) | 1.80068055 |
149 | Increased CSF protein (HP:0002922) | 1.79969643 |
150 | Flat capital femoral epiphysis (HP:0003370) | 1.79632183 |
151 | Oligomenorrhea (HP:0000876) | 1.79576316 |
152 | Metaphyseal cupping (HP:0003021) | 1.79282198 |
153 | Orthostatic hypotension (HP:0001278) | 1.79129536 |
154 | Hypoplastic pelvis (HP:0008839) | 1.78918708 |
155 | IgG deficiency (HP:0004315) | 1.78906802 |
156 | Fair hair (HP:0002286) | 1.78735065 |
157 | Hemiplegia (HP:0002301) | 1.78280809 |
158 | Epidermoid cyst (HP:0200040) | 1.77702320 |
159 | Fat malabsorption (HP:0002630) | 1.77602993 |
160 | B lymphocytopenia (HP:0010976) | 1.76948037 |
161 | Arterial thrombosis (HP:0004420) | 1.76625079 |
162 | Absent speech (HP:0001344) | 1.76508463 |
163 | Epileptic encephalopathy (HP:0200134) | 1.76196592 |
164 | Intestinal atresia (HP:0011100) | 1.76136610 |
165 | Broad alveolar ridges (HP:0000187) | 1.75530284 |
166 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.75386029 |
167 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.75386029 |
168 | Abnormal spermatogenesis (HP:0008669) | 1.74805613 |
169 | Abnormality of femoral epiphyses (HP:0006499) | 1.74526354 |
170 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.74526354 |
171 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73934216 |
172 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73934216 |
173 | Spastic gait (HP:0002064) | 1.73611323 |
174 | Anteriorly placed anus (HP:0001545) | 1.72263762 |
175 | Thickened helices (HP:0000391) | 1.71047400 |
176 | Systemic lupus erythematosus (HP:0002725) | 1.70788222 |
177 | Ketoacidosis (HP:0001993) | 1.68760062 |
178 | Acute encephalopathy (HP:0006846) | 1.67530916 |
179 | Metaphyseal irregularity (HP:0003025) | 1.67302984 |
180 | Abnormal gallbladder morphology (HP:0012437) | 1.66843307 |
181 | Osteoarthritis (HP:0002758) | 1.66269294 |
182 | Dysmetria (HP:0001310) | 1.66204735 |
183 | Aplasia involving bones of the extremities (HP:0009825) | 1.64681245 |
184 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.64681245 |
185 | Aplasia of the phalanges of the hand (HP:0009802) | 1.64681245 |
186 | Hypothermia (HP:0002045) | 1.64677446 |
187 | Intention tremor (HP:0002080) | 1.63936719 |
188 | Onion bulb formation (HP:0003383) | 1.63807828 |
189 | Poor speech (HP:0002465) | 1.63615305 |
190 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.63440068 |
191 | Limb dystonia (HP:0002451) | 1.63027280 |
192 | Submucous cleft hard palate (HP:0000176) | 1.62617808 |
193 | Abnormal pupillary function (HP:0007686) | 1.60661658 |
194 | Acute necrotizing encephalopathy (HP:0006965) | 1.59744726 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.19519516 |
2 | CAMK1D | 3.86906189 |
3 | INSRR | 3.72438666 |
4 | OXSR1 | 3.29778640 |
5 | CASK | 3.13923535 |
6 | MAP4K1 | 2.52607593 |
7 | TEC | 2.42616878 |
8 | BRD4 | 2.30816240 |
9 | ACVR1B | 2.11409836 |
10 | WNK4 | 2.09538114 |
11 | PKN1 | 2.07555974 |
12 | NEK6 | 2.07546309 |
13 | AKT3 | 1.89826053 |
14 | EPHB1 | 1.84066541 |
15 | MET | 1.76662454 |
16 | BCR | 1.75795723 |
17 | FGFR2 | 1.64906133 |
18 | MATK | 1.64030428 |
19 | PRPF4B | 1.60185243 |
20 | IKBKB | 1.58261496 |
21 | FRK | 1.54369035 |
22 | MKNK2 | 1.53680433 |
23 | MST4 | 1.53389028 |
24 | WNK1 | 1.50956314 |
25 | CAMK2B | 1.49166248 |
26 | MAPK15 | 1.48121163 |
27 | PIK3CA | 1.47888795 |
28 | TGFBR2 | 1.44144760 |
29 | IKBKE | 1.38863013 |
30 | NLK | 1.36523818 |
31 | MAP3K14 | 1.33669440 |
32 | FGFR3 | 1.32482533 |
33 | BTK | 1.31908129 |
34 | JAK3 | 1.31483534 |
35 | CAMK2D | 1.31169543 |
36 | KIT | 1.30687051 |
37 | CHUK | 1.30123925 |
38 | TNIK | 1.29769837 |
39 | EIF2AK3 | 1.29470646 |
40 | NUAK1 | 1.29329590 |
41 | SGK223 | 1.29232737 |
42 | SGK494 | 1.29232737 |
43 | MAP4K2 | 1.28699454 |
44 | PNCK | 1.27349383 |
45 | TXK | 1.26092606 |
46 | ERBB4 | 1.26057216 |
47 | EPHA4 | 1.24228127 |
48 | SYK | 1.22376511 |
49 | PRKCE | 1.18321675 |
50 | PDK2 | 1.14907105 |
51 | BMPR2 | 1.14789901 |
52 | MAPKAPK5 | 1.14481289 |
53 | CAMK2G | 1.11420854 |
54 | PLK2 | 1.10412467 |
55 | OBSCN | 1.09487248 |
56 | LCK | 1.09018427 |
57 | FES | 1.07944054 |
58 | LYN | 1.04015015 |
59 | CSF1R | 1.03465661 |
60 | TBK1 | 1.02555036 |
61 | JAK1 | 1.01538561 |
62 | MAP3K13 | 0.98490905 |
63 | GRK7 | 0.98344309 |
64 | JAK2 | 0.97410158 |
65 | PAK3 | 0.97056734 |
66 | CAMK2A | 0.97025920 |
67 | MAPK7 | 0.96805200 |
68 | PHKG2 | 0.95842737 |
69 | PHKG1 | 0.95842737 |
70 | CDK6 | 0.94236750 |
71 | TIE1 | 0.92579939 |
72 | MYLK | 0.91761624 |
73 | BLK | 0.91168676 |
74 | MUSK | 0.90008195 |
75 | PIK3CG | 0.89961339 |
76 | BMPR1B | 0.89872660 |
77 | SGK2 | 0.87749977 |
78 | TYRO3 | 0.86896302 |
79 | BCKDK | 0.86285644 |
80 | TNK2 | 0.85751653 |
81 | MAP3K3 | 0.84946242 |
82 | ITK | 0.84657367 |
83 | MKNK1 | 0.84406605 |
84 | NME1 | 0.84244693 |
85 | IRAK4 | 0.83662579 |
86 | CAMK4 | 0.83501110 |
87 | ERBB3 | 0.83238281 |
88 | FGR | 0.83115887 |
89 | TYK2 | 0.82662723 |
90 | TAOK3 | 0.82610733 |
91 | PRKCQ | 0.80401719 |
92 | ZAP70 | 0.80126068 |
93 | IRAK1 | 0.78358249 |
94 | NTRK1 | 0.78257014 |
95 | RIPK4 | 0.78251572 |
96 | ZAK | 0.77608680 |
97 | MAP3K4 | 0.76992045 |
98 | CSNK1G3 | 0.74741476 |
99 | PRKCH | 0.73913538 |
100 | CSNK1A1L | 0.70492648 |
101 | UHMK1 | 0.70394992 |
102 | HCK | 0.70355447 |
103 | YES1 | 0.70347415 |
104 | DDR2 | 0.69848323 |
105 | GSK3A | 0.69207782 |
106 | CSNK1G1 | 0.68939473 |
107 | ROCK2 | 0.68917330 |
108 | MAP3K5 | 0.68653316 |
109 | EPHA3 | 0.68592969 |
110 | IRAK2 | 0.67522654 |
111 | STK38L | 0.67515668 |
112 | CSK | 0.66539772 |
113 | PBK | 0.63779706 |
114 | DYRK1A | 0.62583132 |
115 | PRKAA2 | 0.62190898 |
116 | CAMK1G | 0.61305544 |
117 | SGK3 | 0.59607519 |
118 | SIK2 | 0.59098829 |
119 | LIMK1 | 0.58726396 |
120 | ADRBK2 | 0.57600746 |
121 | NTRK3 | 0.57384751 |
122 | CDK5 | 0.56983578 |
123 | MAP2K4 | 0.56443781 |
124 | FGFR4 | 0.56274726 |
125 | STK24 | 0.56156889 |
126 | DYRK1B | 0.55873071 |
127 | ABL1 | 0.55733911 |
128 | CSNK1G2 | 0.54542955 |
129 | NEK9 | 0.54506737 |
130 | MAP2K7 | 0.54496203 |
131 | RPS6KA1 | 0.54287449 |
132 | PRKG1 | 0.53989911 |
133 | PDPK1 | 0.52162493 |
134 | PDK4 | 0.51989365 |
135 | PDK3 | 0.51989365 |
136 | RPS6KA4 | 0.51937555 |
137 | PIM1 | 0.51727362 |
138 | MAP3K7 | 0.50360538 |
139 | EGFR | 0.50199875 |
140 | PINK1 | 0.50145148 |
141 | CAMKK2 | 0.48958495 |
142 | LMTK2 | 0.48453567 |
143 | GRK1 | 0.47844625 |
144 | MAPK13 | 0.47806787 |
145 | PDGFRB | 0.47251962 |
146 | IGF1R | 0.46737411 |
147 | PRKACA | 0.46117283 |
148 | SGK1 | 0.45691228 |
149 | PRKACB | 0.45528624 |
150 | WNK3 | 0.45511598 |
151 | CAMK1 | 0.45337287 |
152 | IRAK3 | 0.44874687 |
153 | MAP2K2 | 0.44753550 |
154 | MAP3K2 | 0.44724081 |
155 | CDK19 | 0.44703775 |
156 | CDK3 | 0.44601355 |
157 | PRKCG | 0.44323793 |
158 | HIPK2 | 0.44119207 |
159 | MAPK12 | 0.43507604 |
160 | PDGFRA | 0.34725139 |
161 | MARK3 | 0.34447793 |
162 | MAPK1 | 0.32056166 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.04021659 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.82222107 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.78365222 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.65459211 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.44348646 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43366650 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32744497 |
8 | Asthma_Homo sapiens_hsa05310 | 2.30789129 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.28571125 |
10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.25340302 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.24254635 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23140084 |
13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.18166964 |
14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17995398 |
15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.14469194 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.12256681 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.08852271 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07492825 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.05221268 |
20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03063542 |
21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01923760 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00833863 |
23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97162938 |
24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.94145968 |
25 | Protein export_Homo sapiens_hsa03060 | 1.91774765 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.91278889 |
27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.89365757 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.73615632 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73543748 |
30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68521927 |
31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66241811 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.64172253 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54374420 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53342539 |
35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52710647 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.45260076 |
37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.42906886 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42859074 |
39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42802789 |
40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40723422 |
41 | Malaria_Homo sapiens_hsa05144 | 1.40339969 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.39770240 |
43 | Influenza A_Homo sapiens_hsa05164 | 1.39567708 |
44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39155685 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37943642 |
46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.35038251 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34481446 |
48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31797347 |
49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31624309 |
50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26389658 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24108272 |
52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22162924 |
53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22074731 |
54 | Measles_Homo sapiens_hsa05162 | 1.20947414 |
55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.19981398 |
56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18189829 |
57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18177300 |
58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15912979 |
59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15610668 |
60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15108576 |
61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14296041 |
62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13986871 |
63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11847881 |
64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11809479 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11045923 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10461083 |
67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08845118 |
68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08393919 |
69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07190131 |
70 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06796216 |
71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05707896 |
72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05313587 |
73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02512128 |
74 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00877775 |
75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.00516004 |
76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98882483 |
77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96044971 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94471889 |
79 | Hepatitis B_Homo sapiens_hsa05161 | 0.93230591 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91725500 |
81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91724920 |
82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91367682 |
83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91204744 |
84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90982124 |
85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90422313 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.88318251 |
87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87426944 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86012115 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84615072 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.84067648 |
91 | Salmonella infection_Homo sapiens_hsa05132 | 0.82649801 |
92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82095574 |
93 | Nicotine addiction_Homo sapiens_hsa05033 | 0.82057854 |
94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81547329 |
95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.81487904 |
96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80095128 |
97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78823262 |
98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78220760 |
99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.77742258 |
100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77671259 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77594191 |
102 | Morphine addiction_Homo sapiens_hsa05032 | 0.77467331 |
103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75862794 |
104 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75855382 |
105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75649147 |
106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75167519 |
107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73408498 |
108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72217541 |
109 | Insulin secretion_Homo sapiens_hsa04911 | 0.71821143 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71215848 |
111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71025765 |
112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69944712 |
113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68758468 |
114 | Renin secretion_Homo sapiens_hsa04924 | 0.68010328 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63097680 |
116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62895333 |
117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62720960 |
118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62250918 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62098874 |
120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61303940 |
121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59771253 |
122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59287632 |
123 | Platelet activation_Homo sapiens_hsa04611 | 0.59182262 |
124 | Shigellosis_Homo sapiens_hsa05131 | 0.57880470 |
125 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57655838 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57078960 |
127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57077422 |
128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55902728 |
129 | Long-term depression_Homo sapiens_hsa04730 | 0.55440670 |
130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.54379986 |
131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52504032 |
132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51645205 |
133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50832155 |
134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50297230 |
135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50046943 |
136 | Phagosome_Homo sapiens_hsa04145 | 0.49072847 |
137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48988083 |
138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48874091 |
139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48609394 |
140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48135478 |
141 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.47955390 |
142 | Taste transduction_Homo sapiens_hsa04742 | 0.47881449 |
143 | Axon guidance_Homo sapiens_hsa04360 | 0.47160029 |
144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46462944 |
145 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46425502 |
146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45791938 |
147 | Bile secretion_Homo sapiens_hsa04976 | 0.45357198 |
148 | Hepatitis C_Homo sapiens_hsa05160 | 0.41394257 |
149 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39229108 |
150 | Lysosome_Homo sapiens_hsa04142 | 0.39025624 |
151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38978475 |
152 | Apoptosis_Homo sapiens_hsa04210 | 0.38461436 |
153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37959283 |
154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37495463 |
155 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37488409 |
156 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37366493 |
157 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36583005 |
158 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36208252 |
159 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35938892 |
160 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35655819 |
161 | Prostate cancer_Homo sapiens_hsa05215 | 0.35385629 |
162 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32721661 |
163 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31791188 |
164 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31167457 |
165 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30802724 |
166 | Mineral absorption_Homo sapiens_hsa04978 | 0.30287982 |
167 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24383039 |
168 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.23589237 |
169 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22667548 |